BVX.L
BiVictriX Therapeutics PLC
Price:  
10.00 
GBP
Volume:  
1,054,990.00
United Kingdom | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BVX.L WACC - Weighted Average Cost of Capital

The WACC of BiVictriX Therapeutics PLC (BVX.L) is 12.6%.

The Cost of Equity of BiVictriX Therapeutics PLC (BVX.L) is 12.90%.
The Cost of Debt of BiVictriX Therapeutics PLC (BVX.L) is 5.00%.

Range Selected
Cost of equity 11.40% - 14.40% 12.90%
Tax rate 15.30% - 15.60% 15.45%
Cost of debt 5.00% - 5.00% 5.00%
WACC 11.2% - 14.1% 12.6%
WACC

BVX.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 1.24 1.35
Additional risk adjustments 0.0% 0.5%
Cost of equity 11.40% 14.40%
Tax rate 15.30% 15.60%
Debt/Equity ratio 0.03 0.03
Cost of debt 5.00% 5.00%
After-tax WACC 11.2% 14.1%
Selected WACC 12.6%